PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Gires, O. ; Pan, M.* ; Schinke, H.* ; Canis, M.* ; Baeuerle, P.A.*

Expression and function of epithelial cell adhesion molecule EpCAM: Where are we after 40 years?

Cancer Metastasis Rev. 39, 969–987 (2020)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
EpCAM (epithelial cell adhesion molecule) was discovered four decades ago as a tumor antigen on colorectal carcinomas. Owing to its frequent and high expression on carcinomas and their metastases, EpCAM serves as a prognostic marker, a therapeutic target, and an anchor molecule on circulating and disseminated tumor cells (CTCs/DTCs), which are considered the major source for metastatic cancer cells. Today, EpCAM is reckoned as a multi-functional transmembrane protein involved in the regulation of cell adhesion, proliferation, migration, stemness, and epithelial-to-mesenchymal transition (EMT) of carcinoma cells. To fulfill these functions, EpCAM is instrumental in intra- and intercellular signaling as a full-length molecule and following regulated intramembrane proteolysis, generating functionally active extra- and intracellular fragments. Intact EpCAM and its proteolytic fragments interact with claudins, CD44, E-cadherin, epidermal growth factor receptor (EGFR), and intracellular signaling components of the WNT and Ras/Raf pathways, respectively. This plethora of functions contributes to shaping intratumor heterogeneity and partial EMT, which are major determinants of the clinical outcome of carcinoma patients. EpCAM represents a marker for the epithelial status of primary and systemic tumor cells and emerges as a measure for the metastatic capacity of CTCs. Consequentially, EpCAM has reclaimed potential as a prognostic marker and target on primary and systemic tumor cells.
Impact Factor
Scopus SNIP
Altmetric
6.400
1.455
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Epcam ; Carcinoma ; Metastasis ; Regulated Intramembrane Proteolysis ; Liquid Biopsy ; Epithelial-to-mesenchymal Transition; Circulating Tumor-cells; Breast-cancer Patients; Monoclonal-antibody Therapy; Amyloid Precursor Protein; To-mesenchymal Transition; Ep-cam; Colorectal-carcinoma; Colon-cancer; Phase-i; Intratumoral Heterogeneity
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 0167-7659
e-ISSN 1573-7233
Zeitschrift Cancer and Metastasis Reviews
Quellenangaben Band: 39, Heft: , Seiten: 969–987 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort Dordrecht, Netherlands
Begutachtungsstatus Peer reviewed
Institut(e) Translational Metabolic Oncology (IDC-TMO)
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Radiation Sciences
PSP-Element(e) G-521800-001
DOI 10.1007/s10555-020-09898-3
WOS ID WOS:000538703300001
Scopus ID 85086097366
PubMed ID 32507912
Erfassungsdatum 2020-06-10
[➜Korrektur melden]